Methods: This clinical trials open, randomized, controlled enrolled 160 children aged 6 to 11 years, who were diagnosed functional constipation ROME III, randomly assigned to receive either lactulose 10g/15ml (1.5 ml / kg / day) or PEG 4000 (0.5 g / kg / day) for 3 months.